The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Viret Jean-frederic since 2013.
This trader's CIK number is 1427569.
At the time of last reporting, Viret Jean-frederic was the Chief Financial Officer of Coherus Biosciences, Inc.. (stock ticker symbol CHRS).
Also see all insider trading activities at Coherus Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CHRS | 0 | $0 | 53,546 | $1,061,628 | 47,402 | $476,390 |
| 2020 | CHRS | 0 | $0 | 18,894 | $370,324 | 10,977 | $115,492 |
| 2019 | CHRS | 0 | $0 | 33,861 | $659,679 | 18,954 | $190,483 |
| 2018 | CHRS | 0 | $0 | 9,291 | $172,468 | 740 | $9,990 |
| 2017 | CHRS | 0 | $0 | 3,900 | $105,300 | 3,900 | $52,650 |
| 2016 | CHRS | 0 | $0 | 15,600 | $456,275 | 18,592 | $250,991 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | DDXS | 0 | $0 | 0 | $0 | 2,108 | $590 |
| 2013 | DDXS | 0 | $0 | 0 | $0 | 2,540 | $711 |
1. Coherus Biosciences, Inc. (CHRS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-01 | CHRS | Option Ex | 7,402 | 10.05 | 74,390 |
| 2021-02-01 | CHRS | Sale | 7,402 | 21.55 | 159,513 |
| 2021-01-25 | CHRS | Option Ex | 40,000 | 10.05 | 402,000 |
| 2021-01-25 | CHRS | Sale | 46,144 | 19.55 | 902,115 |
| 2020-11-17 | CHRS | Sale | 1,995 | 17.49 | 34,896 |
| 2020-11-17 | CHRS | Option Ex | 1,500 | 13.50 | 20,250 |
| 2020-10-14 | CHRS | Sale | 6,144 | 19.00 | 116,736 |
| 2020-05-20 | CHRS | Sale | 1,278 | 17.66 | 22,569 |
| 2020-02-19 | CHRS | Option Ex | 3,159 | 10.05 | 31,747 |
| 2020-02-19 | CHRS | Sale | 3,159 | 22.33 | 70,553 |
| 2020-01-15 | CHRS | Sale | 6,318 | 19.88 | 125,570 |
| 2020-01-15 | CHRS | Option Ex | 6,318 | 10.05 | 63,495 |
| 2019-11-20 | CHRS | Option Ex | 3,159 | 10.05 | 31,747 |
| 2019-11-20 | CHRS | Sale | 3,159 | 19.59 | 61,872 |
| 2019-11-18 | CHRS | Sale | 3,112 | 18.88 | 58,757 |
| 2019-10-18 | CHRS | Sale | 1,388 | 19.02 | 26,399 |
| 2019-10-16 | CHRS | Option Ex | 3,159 | 10.05 | 31,747 |
| 2019-10-16 | CHRS | Sale | 3,159 | 19.00 | 60,021 |
| 2019-09-23 | CHRS | Sale | 740 | 21.78 | 16,117 |
| 2019-09-18 | CHRS | Option Ex | 3,159 | 10.05 | 31,747 |
| 2019-09-18 | CHRS | Sale | 3,159 | 20.44 | 64,560 |
| 2019-08-21 | CHRS | Sale | 6,318 | 21.24 | 134,181 |
| 2019-08-21 | CHRS | Option Ex | 6,318 | 10.05 | 63,495 |
| 2019-08-19 | CHRS | Sale | 3,000 | 19.04 | 57,120 |
| 2019-06-19 | CHRS | Option Ex | 3,159 | 10.05 | 31,747 |
| 2019-06-18 | CHRS | Sale | 3,000 | 19.31 | 57,927 |
| 2019-06-19 | CHRS | Sale | 3,826 | 20.38 | 77,962 |
| 2019-03-20 | CHRS | Sale | 3,000 | 14.92 | 44,763 |
| 2018-09-21 | CHRS | Option Ex | 740 | 13.50 | 9,990 |
| 2018-07-23 | CHRS | Sale | 9,291 | 18.56 | 172,468 |
| 2017-01-25 | CHRS | Sale | 3,900 | 27.00 | 105,300 |
| 2017-01-25 | CHRS | Option Ex | 3,900 | 13.50 | 52,650 |
| 2016-12-19 | CHRS | Option Ex | 667 | 13.50 | 9,004 |
| 2016-12-16 | CHRS | Sale | 3,900 | 28.30 | 110,366 |
| 2016-12-16 | CHRS | Option Ex | 3,900 | 13.50 | 52,650 |
| 2016-11-18 | CHRS | Option Ex | 3,900 | 13.50 | 52,650 |
| 2016-11-18 | CHRS | Sale | 3,900 | 28.19 | 109,956 |
| 2016-10-21 | CHRS | Sale | 3,900 | 30.62 | 119,402 |
| 2016-10-21 | CHRS | Option Ex | 3,900 | 13.50 | 52,650 |
| 2016-09-26 | CHRS | Sale | 3,900 | 29.89 | 116,551 |
| 2016-09-26 | CHRS | Option Ex | 3,900 | 13.50 | 52,650 |
| 2016-07-06 | CHRS | Option Ex | 1,925 | 13.50 | 25,987 |
| 2016-03-28 | CHRS | Option Ex | 400 | 13.50 | 5,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-04-28 | DDXS | Option Ex | 2,108 | .28 | 590 |
| 2013-03-27 | DDXS | Option Ex | 2,540 | .28 | 711 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Viret Jean-frederic (Chief Financial Officer of Coherus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.